Carcinoma News and Research

RSS
Carcinoma is cancer that begins in the skin or in tissues that line or cover internal organs.
Simvastatin is a promising drug candidate for treatment of ovarian clear cell carcinomas

Simvastatin is a promising drug candidate for treatment of ovarian clear cell carcinomas

Study: MRI is reliable for intrapelvic T staging of neuroendocrine carcinoma

Study: MRI is reliable for intrapelvic T staging of neuroendocrine carcinoma

Reduced-dose radiotherapy with cisplatin produces good outcomes for HPV-associated oropharyngeal cancer

Reduced-dose radiotherapy with cisplatin produces good outcomes for HPV-associated oropharyngeal cancer

Genetic changes in tumors can help predict the efficacy of immunotherapy drugs

Genetic changes in tumors can help predict the efficacy of immunotherapy drugs

Allarity Therapeutics announces plans to test antiviral activity of stenoparib drug

Allarity Therapeutics announces plans to test antiviral activity of stenoparib drug

Wistar researchers discover new enzymatic function of the Epstein-Barr Virus protein

Wistar researchers discover new enzymatic function of the Epstein-Barr Virus protein

Study finds high prevalence of cardiovascular conditions in male breast cancer patients

Study finds high prevalence of cardiovascular conditions in male breast cancer patients

Reduced expression of TBX15 in tumor tissue represents a prognostic biomarker for HCC patients

Reduced expression of TBX15 in tumor tissue represents a prognostic biomarker for HCC patients

Combination therapy shows potential for treating lung cancer

Combination therapy shows potential for treating lung cancer

SU2C announces $3.25 million in grants to find new treatments for head and neck cancers

SU2C announces $3.25 million in grants to find new treatments for head and neck cancers

Potentially promising therapeutic combination for renal cell carcinoma uncovered

Potentially promising therapeutic combination for renal cell carcinoma uncovered

Researchers design armored immune cells to attack recurring cancer in liver transplant patients

Researchers design armored immune cells to attack recurring cancer in liver transplant patients

Research finds new evidence about the mechanisms controlling skin repair and regeneration

Research finds new evidence about the mechanisms controlling skin repair and regeneration

CoQ10 supplement could be a valuable complementary therapeutic option for various diseases

CoQ10 supplement could be a valuable complementary therapeutic option for various diseases

Study: NTRK fusions are far more frequently seen in pediatric tumors

Study: NTRK fusions are far more frequently seen in pediatric tumors

Newly discovered biochemical pathway can protect cells from ferroptosis

Newly discovered biochemical pathway can protect cells from ferroptosis

ARID1A gene in ovarian cancer plays a role in the regulation of metabolism

ARID1A gene in ovarian cancer plays a role in the regulation of metabolism

Researchers investigate prognostic role of diversity of chromatin compartments in gynecological cancers

Researchers investigate prognostic role of diversity of chromatin compartments in gynecological cancers

Proteogenomics can help determine effective treatment for head and neck squamous cell carcinoma

Proteogenomics can help determine effective treatment for head and neck squamous cell carcinoma

Repurposed drug can treat hearing loss in humans

Repurposed drug can treat hearing loss in humans

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.